申请人:Bös Michael
公开号:US20090312366A1
公开(公告)日:2009-12-17
The present application is directed to novel P2X7R antagonists that are indol-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
本申请涉及新型P2X7R拮抗剂,其为吲哚-3-羧酰胺或氮杂吲哚-3-羧酰胺化合物,包括这些化合物的药物组合物,以及它们用于预防或治疗由P2X7R活性介导的疾病。